Matches in Nanopublications for { ?s <http://www.w3.org/2000/01/rdf-schema#label> ?o ?g. }
- association label "Antihistamine agents, such as hydroxyzine or diphenhy- dramine, are the most widely prescribed sedatives in the pediatric practice but evidence supporting their use is still limited." assertion.
- association label "Limited evidence supports the use of alpha-agonists such as clonidine to improve sleep onset latency, especially in attention deficit/hyperactivity disorder subjects." assertion.
- cohort label "Children" assertion.
- cohort label "Children" assertion.
- association label "Only few studies have been carried out in children’s and adolescents’ zolpidem, zaleplon, and eszopiclone, with contrasting results." assertion.
- cohort label "Children" assertion.
- association label "A small randomized and placebo-controlled study of quetiapine (25 mg/nocte, a relatively low dose) in adults showed a statistically nonsignificant trend toward improvement in total sleep time and reduced sleep latency (Tassniyom, Paholpak, Tassniyom, & Kiewyoo, 2010)." assertion.
- COVID-KG label "COVID KG" assertion.
- COVID-KG label "COVID KG" assertion.
- M4M-metadata label "M4M metadata workshop" assertion.
- M4M-metadata label "M4M metadata workshop" assertion.
- M4M-metadata label "M4M metadata workshop" assertion.
- M4M-metadata label "M4M metadata workshop" assertion.
- M4M-metadata label "M4M metadata workshop" assertion.
- R4RM4M label "R4RM4M workshop" assertion.
- R4RM4M label "R4RM4M workshop" assertion.
- R4RM4M label "R4RM4M workshop" assertion.
- R4RM4M label "R4RM4M workshop" assertion.
- R4RM4M label "R4RM4M workshop" assertion.
- M4M-infrastructure label "M4M infrastructure workshop" assertion.
- M4M-infrastructure label "M4M infrastructure workshop" assertion.
- M4M-infrastructure label "M4M infrastructure workshop" assertion.
- M4M-infrastructure label "M4M infrastructure workshop" assertion.
- M4M-infrastructure label "M4M infrastructure workshop" assertion.
- M4M-FIP label "M4M FIP workshop" assertion.
- M4M-FIP label "M4M FIP workshop" assertion.
- M4M-FIP label "M4M FIP workshop" assertion.
- workshop label "short ID of workshop" assertion.
- name label "the name of the workshop" assertion.
- workshoptype label "choose the type of the workshop" assertion.
- date label "date of the workshop (e.g. 2020-12-01)" assertion.
- assertion label "Defining an M4M workshop" assertion.
- workshoptype label "choose the type of the workshop" assertion.
- name label "the name of the workshop" assertion.
- workshop label "short ID of workshop" assertion.
- date label "date of the workshop (e.g. 2020-12-01)" assertion.
- assertion label "Defining an M4M workshop" assertion.
- somebodyElse label "ORCID identifier of the person to be attributed" assertion.
- assertion label "Attributed to somebody else" assertion.
- cohort label "Adults" assertion.
- association label "Recently, off label use of modafinil (MOD), an approved medication for treatment of sleep disturbances, has been tested as a therapeutic for cocaine and methamphetamine use disorder. Positive results have been found in subjects dependent on psychostimulants without concurrent abuse of other substances." assertion.
- cohort label "Adults" assertion.
- association label "Recently, off label use of modafinil (MOD), an approved medication for treatment of sleep disturbances, has been tested as a therapeutic for cocaine and methamphetamine use disorder. Positive results have been found in subjects dependent on psychostimulants without concurrent abuse of other substances." assertion.
- cohort label "Adults" assertion.
- association label "Recently, off label use of modafinil (MOD), an approved medication for treatment of sleep disturbances, has been tested as a therapeutic for cocaine and methamphetamine use disorder. Positive results have been found in subjects dependent on psychostimulants without concurrent abuse of other substances." assertion.
- association label "Tazodone, a serotonin modulator, is used off-label for insomnia." assertion.
- cohort label "Adults" assertion.
- association label "Trazodone is also used off-label for anxiety, Alzheimer disease, substance abuse, bulimia, and fibromyalgia due to its serotonergic receptor antagonism and serotonin reuptake inhibiting effects." assertion.
- cohort label "Adults" assertion.
- association label "Trazodone is also used off-label for anxiety, Alzheimer disease, substance abuse, bulimia, and fibromyalgia due to its serotonergic receptor antagonism and serotonin reuptake inhibiting effects." assertion.
- cohort label "Adults" assertion.
- cohort label "Adults" assertion.
- association label "Trazodone is also used off-label for anxiety, Alzheimer disease, substance abuse, bulimia, and fibromyalgia due to its serotonergic receptor antagonism and serotonin reuptake inhibiting effects." assertion.
- cohort label "Adults" assertion.
- association label "In this activity, augmentation and adjunctive strategies involving atypical antipsychotics, as well as off-label options including buspirone, stimulants, thyroid hormone, and lithium, are reviewed. ." assertion.
- cohort label "Adults" assertion.
- association label "It also has off label use as monotherapy or adjunctive therapy for the treatment of mania, restless leg syndrome, insomnia, tardive dyskinesia, and REM sleep behavior disorder." assertion.
- cohort label "Adults" assertion.
- association label "It also has off label use as monotherapy or adjunctive therapy for the treatment of mania, restless leg syndrome, insomnia, tardive dyskinesia, and REM sleep behavior disorder." assertion.
- association label "The drug has sedative, antiemetic, anxiolytic, and appetite stimulant effects, which explains its off-label use for the following conditions: insomnia, panic disorder, post-traumatic stress disorder, obsessive-compulsive disorder, generalized anxiety disorder, social anxiety disorder, headaches, and migraines." assertion.
- cohort label "Adults" assertion.
- cohort label "Adults" assertion.
- association label "The drug has sedative, antiemetic, anxiolytic, and appetite stimulant effects, which explains its off-label use for the following conditions: insomnia, panic disorder, post-traumatic stress disorder, obsessive-compulsive disorder, generalized anxiety disorder, social anxiety disorder, headaches, and migraines." assertion.
- cohort label "Adults" assertion.
- association label "The drug has sedative, antiemetic, anxiolytic, and appetite stimulant effects, which explains its off-label use for the following conditions: insomnia, panic disorder, post-traumatic stress disorder, obsessive-compulsive disorder, generalized anxiety disorder, social anxiety disorder, headaches, and migraines." assertion.
- cohort label "Adults" assertion.
- association label "The drug has sedative, antiemetic, anxiolytic, and appetite stimulant effects, which explains its off-label use for the following conditions: insomnia, panic disorder, post-traumatic stress disorder, obsessive-compulsive disorder, generalized anxiety disorder, social anxiety disorder, headaches, and migraines." assertion.
- association label "Off-label use includes treatment of cholestatic pruritus in adults." assertion.
- cohort label "Adults" assertion.
- association label "Sedating antidepressants (e.g., amitriptyline, trazodone, mirtazapine) are often prescribed off-label as sleeping aids" assertion.
- cohort label "Adults" assertion.
- cohort label "Children and adolescents" assertion.
- association label "Melatonin (97%), trazodone (81%), and quetiapine (73%) were rated by a majority of respondents as effective. Doxepin, zaleplon, tricyclic antidepressants, zolpidem, or lorazepam were rarely prescribed due to lack of evidence and/or concerns about adverse effects, long-term safety, suitability for youth, suicidality, and dependence/tolerance." assertion.
- association label "Melatonin (97%), trazodone (81%), and quetiapine (73%) were rated by a majority of respondents as effective. Doxepin, zaleplon, tricyclic antidepressants, zolpidem, or lorazepam were rarely prescribed due to lack of evidence and/or concerns about adverse effects, long-term safety, suitability for youth, suicidality, and dependence/tolerance." assertion.
- cohort label "Children and adolescents" assertion.
- cohort label "Children and adolescents" assertion.
- association label "Melatonin (97%), trazodone (81%), and quetiapine (73%) were rated by a majority of respondents as effective. Doxepin, zaleplon, tricyclic antidepressants, zolpidem, or lorazepam were rarely prescribed due to lack of evidence and/or concerns about adverse effects, long-term safety, suitability for youth, suicidality, and dependence/tolerance." assertion.
- cohort label "Children and adolescents" assertion.
- association label "Melatonin (97%), trazodone (81%), and quetiapine (73%) were rated by a majority of respondents as effective. Doxepin, zaleplon, tricyclic antidepressants, zolpidem, or lorazepam were rarely prescribed due to lack of evidence and/or concerns about adverse effects, long-term safety, suitability for youth, suicidality, and dependence/tolerance." assertion.
- association label "Prescriptions for antipsychotic medications continue to increase across many brain disorders, including off-label use in children and elderly individuals." assertion.
- cohort label "Elderly; adults" assertion.
- spi label "the protein TDP-43 represses cryptic exon inclusion in the gene UNC13A" assertion.
- creator label "ORCID identifier of the person who performed the formalization" assertion.
- activity label "Formalization-Activity" assertion.
- quote label "source quote" assertion.
- source label "URI of the source used by this formalization activity" assertion.
- assertion label "Generated by a formalization activity" assertion.
- M4M-workshop label "M4M workshop" assertion.
- M4M-vocabulary label "M4M vocabulary workshop" assertion.
- M4M-vocabulary label "M4M vocabulary workshop" assertion.
- M4M-vocabulary label "M4M vocabulary workshop" assertion.
- M4M-vocabulary label "M4M vocabulary workshop" assertion.
- M4M-vocabulary label "M4M vocabulary workshop" assertion.
- R4RM4M label "R4RM4M workshop" assertion.
- R4RM4M label "R4RM4M workshop" assertion.
- R4RM4M label "R4RM4M workshop" assertion.
- R4RM4M label "R4RM4M workshop" assertion.
- R4RM4M label "R4RM4M workshop" assertion.
- M4M-infrastructure label "M4M infrastructure workshop" assertion.
- M4M-infrastructure label "M4M infrastructure workshop" assertion.